Last Updated on Feb 13, 2020

Latest Publications and Research on Uterine Cancer

Drug Discov. Today  2020 Jan 27  

From patent to patient: analysing access to innovative cancer drugs.

Sharpe E, Hoey R, Yap C, Workman P

Analysis of cancer drugs licensed through the European Medicines Agency (EMA) in 2000-2016 shows that the number of authorisations increased over that... Read More

Source: PubMed


Updates Surg  2020 Feb 01  

Updates in office hysteroscopy: a practical decalogue to perform a correct procedure.

Vitale SG, Bruni S, Chiofalo B, Riemma G, Lasmar RB

Nowadays, hysteroscopy is the gold standard for the diagnosis and treatment of intrauterine pathologies as it represents a safe and minimally invasive... Read More

Source: PubMed

Biochem. Biophys. Res. Commun.  2020 Jan 29  

Dedifferentiation of neuroendocrine carcinoma of the uterine cervix in hypoxia.

Kubota S, Tanaka M, Endo H, Ito Y, Onuma K, Ueda Y, Kamiura S, Yoshino K, Kimura T, Kondo J, Inoue M

Neuroendocrine carcinoma of small cell type (SCNEC) is a rare pathological subtype in cervical cancer, which has a worse prognosis than other histolog... Read More

Source: PubMed

J Transl Med    

Dynamic changes of angiopoietins and endothelial nitric oxide supply during fluid resuscitation for major gyn-oncological surgery: a prospective observation.

Gehlen J, Klaschik S, Neumann C, Keyver-Paik MD, Mustea A, Soehle M, Frede S, Velten M, Hoeft A, Hilbert T

Despite goal-directed hemodynamic therapy, vascular function may deteriorate during surgery for advanced abdominal tumor masses. Fluid administration ... Read More

Source: PubMed

Int. J. Radiat. Oncol. Biol. Phys.  2020 Jan 28  

Impact of Patient Stage and Disease Characteristics on the proposed Radiation Oncology Alternative Payment Model (RO-APM).

Waddle MR, Stross WC, Vallow LA, Naessens JM, White L, Meier S, Spaulding AC, Buskirk SJ, Trifiletti DM, Keole SR, Ma DJ, Bajaj GK, Laack NN, Miller RC

The proposed Radiation Oncology Alternative Payment Model (RO-APM) released on July 10, 2019, represents a dramatic shift from fee-for-service (FFS) r... Read More

Source: PubMed

Updates Surg  2020 Feb 01  

Updates in office hysteroscopy: a practical decalogue to perform a correct procedure.

Vitale SG, Bruni S, Chiofalo B, Riemma G, Lasmar RB

Nowadays, hysteroscopy is the gold standard for the diagnosis and treatment of intrauterine pathologies as it represents a safe and minimally invasive... Read More

Source: PubMed

Biochem. Biophys. Res. Commun.  2020 Jan 29  

Dedifferentiation of neuroendocrine carcinoma of the uterine cervix in hypoxia.

Kubota S, Tanaka M, Endo H, Ito Y, Onuma K, Ueda Y, Kamiura S, Yoshino K, Kimura T, Kondo J, Inoue M

Neuroendocrine carcinoma of small cell type (SCNEC) is a rare pathological subtype in cervical cancer, which has a worse prognosis than other histolog... Read More

Source: PubMed

Drug Discov. Today  2020 Jan 27  

From patent to patient: analysing access to innovative cancer drugs.

Sharpe E, Hoey R, Yap C, Workman P

Analysis of cancer drugs licensed through the European Medicines Agency (EMA) in 2000-2016 shows that the number of authorisations increased over that... Read More

Source: PubMed

J Transl Med    

Dynamic changes of angiopoietins and endothelial nitric oxide supply during fluid resuscitation for major gyn-oncological surgery: a prospective observation.

Gehlen J, Klaschik S, Neumann C, Keyver-Paik MD, Mustea A, Soehle M, Frede S, Velten M, Hoeft A, Hilbert T

Despite goal-directed hemodynamic therapy, vascular function may deteriorate during surgery for advanced abdominal tumor masses. Fluid administration ... Read More

Source: PubMed

Int. J. Radiat. Oncol. Biol. Phys.  2020 Jan 28  

Impact of Patient Stage and Disease Characteristics on the proposed Radiation Oncology Alternative Payment Model (RO-APM).

Waddle MR, Stross WC, Vallow LA, Naessens JM, White L, Meier S, Spaulding AC, Buskirk SJ, Trifiletti DM, Keole SR, Ma DJ, Bajaj GK, Laack NN, Miller RC

The proposed Radiation Oncology Alternative Payment Model (RO-APM) released on July 10, 2019, represents a dramatic shift from fee-for-service (FFS) r... Read More

Source: PubMed

Comments

jadesmith Monday, November 29, 2010

From all the symptoms of endometrial cancer, the commonly noted one is unanticipated or irregular vaginal bleeding post menopause. In case a woman is on a course of hormone therapy then there could be some amount of bleeding from vagina which could be anticipated. Nearly twenty from a hundred females that experience irregular bleeding post menopause have been found to have endometrial cancer. Weight loss without any effort taken could be one of the symptoms of endometrial cancer among women who are in the advanced or later stages of endometrial cancer.

Most Popular on Medindia